Security key
87911K100
- Security type / class
- Equity / Common
- Total 13F shares
- 7,869,347
- Total 13F value
- $156,512,869
- Share change
- -422,065
- SEC-reported price per share
- $20.01
- Number of holders
- 84
- Value change
- -$8,119,986
- Number of buys
- 54
- Number of sells
- 25
- Shares outstanding
- 31,319,065
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
84
Top holders
10
HQL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Previous quarter: Q1 2026
abrdn Life Sciences Investors SEC filings
Broader feeds
Reporting periods
Holder history for CUSIP 87911K100
Recent filing periods:
Ownership snapshot
Top reported holders of HQL - abrdn Life Sciences Investors - Common (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Saba Capital Management, ...
Disclosed value leader
Saba Capital Management, ...
Comparable rows
15/15
Latest evidence
31 Mar 2026
3/4/5
13D/G
13F
Lead comparable stake: 5%
13D/G row: Saba Capital Management, L.P.
Showing 1-6 of 15 holder rows.
Quick read
Saba Capital Management, L.P. leads the comparable SEC ownership view at 5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Saba Capital Management, L.P.'s linked filing trail.
Comparable ownership
Top 5
Saba Capital Management, L.P.
5%
Christian Pittard
0.03%
MORGAN STANLEY
5%
Penserra Capital Management LLC
2.6%
RAYMOND JAMES FINANCIAL INC
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Saba Capital Management, L.P. |
3/4/5
13D/G
13F
10%+ Owner · Company
|
5%
from 13D/G
|
$40,124,130
2,837,633 shares
|
— | 19 Sep 2025 |
| Christian Pittard |
3/4/5
Director
|
0.03%
|
$133,754
7,923 shares
|
+$133,755 | 16 Dec 2025 |
| MORGAN STANLEY |
13F
Company
|
5%
|
$25,560,421
1,571,014 shares
|
— | 31 Mar 2026 |
| Penserra Capital Management LLC |
13F
Company
|
2.6%
|
$13,128,000
806,888 shares
|
— | 31 Mar 2026 |
| RAYMOND JAMES FINANCIAL INC |
13F
Company
|
2.1%
|
$10,759,541
661,312 shares
|
— | 31 Mar 2026 |
| LPL Financial LLC |
13F
Company
|
1.5%
|
$7,790,115
478,802 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
84
Shares
7,869,347
Rows available
84
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
87
Q2 2026 holders
84
Holder diff
-3
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend